Regis Healthcare Limited (ASX:REG)
Australia
· Delayed Price · Currency is AUD 6.88
+0.11 (1.62%)
Mar 28, 2025, 4:10 PM AEST
Regis Healthcare Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 1,098 | 1,014 | 780.61 | 725.33 | 701.37 | 677.87 | Upgrade
|
| Revenue Growth (YoY) | 24.75% | 29.90% | 7.62% | 3.42% | 3.47% | 4.79% | Upgrade
|
| Cost of Revenue | 902.71 | 838.8 | 647.27 | 609.61 | 574.43 | 541.2 | Upgrade
|
| Gross Profit | 195.43 | 175.25 | 133.34 | 115.72 | 126.93 | 136.67 | Upgrade
|
| Selling, General & Admin | 82.04 | 80.47 | 76.77 | 66.14 | 62.93 | 59.85 | Upgrade
|
| Operating Expenses | 171.3 | 208.55 | 203.24 | 169.25 | 106.82 | 103.92 | Upgrade
|
| Operating Income | 24.14 | -33.3 | -69.9 | -53.53 | 20.11 | 32.76 | Upgrade
|
| Interest Expense | -103.55 | -88.61 | -70.85 | -66.68 | -70.07 | -76.6 | Upgrade
|
| Interest & Investment Income | 102.61 | 85.5 | 63.58 | 62.45 | 64.4 | 67.09 | Upgrade
|
| Other Non Operating Income (Expenses) | -3.13 | -2.87 | -2.75 | -3.7 | -3.93 | -2.2 | Upgrade
|
| EBT Excluding Unusual Items | 20.07 | -39.28 | -79.92 | -61.46 | 10.52 | 21.04 | Upgrade
|
| Merger & Restructuring Charges | -7.59 | -7.59 | - | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -20.57 | Upgrade
|
| Gain (Loss) on Sale of Assets | 5.14 | 5.06 | 11.65 | - | 2.82 | 0.61 | Upgrade
|
| Asset Writedown | - | - | 0.64 | 3.02 | 11.66 | 0.08 | Upgrade
|
| Other Unusual Items | 6.05 | 13.69 | 27.25 | 3.25 | 4.16 | 4.55 | Upgrade
|
| Pretax Income | 23.68 | -28.1 | -40.38 | -55.19 | 29.15 | 5.72 | Upgrade
|
| Income Tax Expense | 8.59 | -6.69 | -11.93 | -16.39 | 9.2 | 6.43 | Upgrade
|
| Net Income | 15.09 | -21.42 | -28.45 | -38.8 | 19.95 | -0.72 | Upgrade
|
| Net Income to Common | 15.09 | -21.42 | -28.45 | -38.8 | 19.95 | -0.72 | Upgrade
|
| Shares Outstanding (Basic) | 301 | 301 | 301 | 301 | 301 | 301 | Upgrade
|
| Shares Outstanding (Diluted) | 302 | 301 | 301 | 301 | 301 | 301 | Upgrade
|
| Shares Change (YoY) | 0.50% | 0.05% | 0.02% | -0.01% | 0.02% | -0.04% | Upgrade
|
| EPS (Basic) | 0.05 | -0.07 | -0.09 | -0.13 | 0.07 | -0.00 | Upgrade
|
| EPS (Diluted) | 0.05 | -0.07 | -0.09 | -0.13 | 0.07 | -0.00 | Upgrade
|
| Free Cash Flow | 241.7 | 186.57 | 53.73 | 67.6 | 87.75 | 87.94 | Upgrade
|
| Free Cash Flow Per Share | 0.80 | 0.62 | 0.18 | 0.23 | 0.29 | 0.29 | Upgrade
|
| Dividend Per Share | 0.147 | 0.129 | 0.095 | 0.058 | 0.066 | 0.040 | Upgrade
|
| Dividend Growth | 7.05% | 36.29% | 62.33% | -11.92% | 64.92% | -73.61% | Upgrade
|
| Gross Margin | 17.80% | 17.28% | 17.08% | 15.95% | 18.10% | 20.16% | Upgrade
|
| Operating Margin | 2.20% | -3.28% | -8.95% | -7.38% | 2.87% | 4.83% | Upgrade
|
| Profit Margin | 1.37% | -2.11% | -3.65% | -5.35% | 2.84% | -0.11% | Upgrade
|
| Free Cash Flow Margin | 22.01% | 18.40% | 6.88% | 9.32% | 12.51% | 12.97% | Upgrade
|
| EBITDA | 112.34 | 93.81 | 55.19 | 48.59 | 63.01 | 75.88 | Upgrade
|
| EBITDA Margin | 10.23% | 9.25% | 7.07% | 6.70% | 8.98% | 11.19% | Upgrade
|
| D&A For EBITDA | 88.2 | 127.11 | 125.09 | 102.12 | 42.9 | 43.12 | Upgrade
|
| EBIT | 24.14 | -33.3 | -69.9 | -53.53 | 20.11 | 32.76 | Upgrade
|
| EBIT Margin | 2.20% | -3.28% | -8.95% | -7.38% | 2.87% | 4.83% | Upgrade
|
| Effective Tax Rate | 36.27% | - | - | - | 31.56% | 112.52% | Upgrade
|
| Revenue as Reported | 1,212 | 1,118 | 897.61 | 796.95 | 784.4 | 750.21 | Upgrade
|
Updated Feb 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.